Corrigendum to Nystatin-induced nitric oxide production in mouse macrophage-like cell line RAW2 64.7. [Microbiology and Immunology, 53, (2009), 295-300], doi: 10.1111/j.1348-0421.2009.00118.x;Nystatin-induced nitric oxide production in mouse macrophage-like cell line RAW264.7

Microbiology and Immunology

Volumn 53, Issue 5, 2009, Pages 295-300

  Koide, Naoki ^a   Naiki, Yoshikazu ^a   Morikawa, Akiko ^a   Tumurkhuu, Gantsetseg ^a   Dagvadorj, Jargalsaikhan ^a   Noman, Abu Shadat Mohammod ^a   Iftekar E Khuda, Imtiaz ^a   Komatsu, Takayuki ^a   Yoshida, Tomoaki ^a   Yokochi, Takashi ^a  

^a AICHI MEDICAL UNIVERSITY SCHOOL OF MEDICINE   (Japan)

Author keywords

Lipopolysaccharide; Nitric oxide; Nystatin; RAW264.7 cells

Indexed keywords

ADENOSINE TRIPHOSPHATASE (POTASSIUM SODIUM); AMILORIDE; GANGLIOSIDE GM1; I KAPPA B; IMMUNOGLOBULIN ENHANCER BINDING PROTEIN; INDUCIBLE NITRIC OXIDE SYNTHASE; LIPOPOLYSACCHARIDE; NITRIC OXIDE; NYSTATIN; PHOSPHATIDYLINOSITOL 3 KINASE; PROTEIN KINASE B; GANGLIOSIDE; I KAPPA B KINASE;

ANIMAL CELL; ARTICLE; CONCENTRATION (PARAMETERS); CONTROLLED STUDY; ENZYME ACTIVATION; LIPID RAFT; MACROPHAGE; MOUSE; NONHUMAN; PROTEIN EXPRESSION; PROTEIN FUNCTION; ANIMAL; CELL LINE; DRUG EFFECT; IMMUNOLOGY; SIGNAL TRANSDUCTION;

MAMMALIA;

ANIMALS; CELL LINE; GANGLIOSIDES; I-KAPPA B KINASE; MACROPHAGES; MICE; NF-KAPPA B; NITRIC OXIDE; NYSTATIN; SIGNAL TRANSDUCTION;

EID: 66849134684     PISSN: 03855600     EISSN: 13480421     Source Type: Journal    
DOI: 10.1111/1348-0421.12236     Document Type: Erratum

References (21)

1. Beckman J.S., Koppenol W.H. (1996) Nitric oxide, super oxide, and peroxynitrite: the good, the bad, and the ugly. Am J Physiol 271: 1424-7.
2. Dimmeler S., Zeiher A.M. (1997) Nitric oxide and apoptosis: another paradigm for the double-edged role of nitric oxide. Nitric Oxide Biol Chem 1: 275-81.
3. Kroncke K.D., Fehsel K., Kolb-Bachofen V. (1997) Nitric oxide: cytotoxicity versus cytoprotection-how, why, when and where? Nitric Oxide Biol Chem 1: 107-20.
4. Magazine H.I. (1995) Detection of endothelial cell-derived nitric oxide: Current trends and future directions. Adv Neuroimmunol 5: 479-90.
5. Nathan C. (1992) Nitric oxide as a secretory product of mammalian cells. FASEB J 6: 3051-64.
6. Lorsbach R.B., Murphy W.J., Lowenstein C.J., Snyder S.H., Russell W. (1993) Expression of the nitric oxide synthase gene in mouse macrophages activated for tumor cell killing. Molecular basis for the synergy between interferon-gamma and lipopolysaccharide. J Biol Chem 268: 1908-13.
7. Morikawa A., KoideN., Kato Y., Sugiyama T., Chakravortty D., Yoshida T., Yokochi T. (2000) Augmentation of nitric oxide production by gamma interferon in a mouse vascular endothelial cell line and its modulation by tumor necrosis factor alpha and lipopolysaccharide. Infect Immun 68: 6209-14.
8. Chen X., Resh M.D. (2002) Cholesterol depletion from the plasma membrane triggers ligand-independent activation of the epidermal growth factor receptor. J Biol Chem 277: 49 631-7.
9. Dai Q., Zhang J., Pruett S.B. (2005) Ethanol alters cellular activation and CD14 partitioning in lipid rafts. Biochem Biophys Res Commun 332: 37-42.
10. Brown D., Rose J.K. (1992) Sorting of GPI-anchored proteins to glycolipid-enriched membrane subdomains during transport to the apical cell surface. Cell 68: 533-44.
11. Koide N., Ito H., Mu M.M., Sugiyama T., Hassan F., Islam S., Mori I., Yoshida T., Yokochi T. (2005) Inhibition of extracellular signal-regulated kinase 1/2 augments nitric oxide production in lipopolysaccharide-stimulated RAW264.7 macrophage cells. FEMS Immunol Med Microbiol 45: 213-19.
12. Morikawa A., Sugiyama T., Koide N., Mori I., Mu M.M., Yoshida T., Hassan F., Islam S., Yokochi T. (2004) Butyrate enhances the production of nitric oxide in mouse vascular endothelial cells in response to gamma interferon. J Endotoxin Res 10: 32-8.
13. Koide N., Morikawa A., Tumurkhuu G., Dagvadorj J., Hassan F., Islam S., Naiki Y., Mori I., Yoshida T., Yokochi T. (2007) Lipopolysaccharide and interferon-gamma enhance Fas-mediated cell death in mouse vascular endothelial cells via augmentation of Fas expression. Clin Exp Immunol 150: 553-60.
14. Koide N., Sugiyama T., Mori I., Mu M.M., Yoshida T., Yokochi T. (2003) C2-ceramide inhibits LPS-induced nitric oxide production in RAW 264.7 macrophage cells through down-regulating the activation of Akt. J Endotoxin Res 9: 85-90.
15. Bolard J. (1986) How do the polyene macrolide antibiotics affect the cellular membrane properties? Biochim Biophys Acta 864: 257-304.
16. Wills N.K. (1981) Antibiotics as tools for studying the electrical properties of tight epithelia. Fed Proc 40: 2202-5.
17. Rouquette-Jazdanian A.K. Foussat A., Lamy L., Pelassy C., Lagadec P., Breittmayer J.P., Aussel C. (2005) Cholera toxin B-subunit prevents activation and proliferation of human CD4+ T cells by activation of a neutral sphingomyelinase in lipid rafts. J Immunol 175: 5637-48.
18. Wolf A.A., Jobling M.G., Saslowsky D.E., Kern E., Drake K.R., Kenworthy A.K., Holmes R.K., Lencer W.I. (2008) Attenuated endocytosis and toxicity of a mutant cholera toxin with decreased ability to cluster ganglioside GM1 molecules. Infect Immun 76: 1476-84.
19. Triantafilou M., Miyake K., Golenbock D.T., Triantafilou K. (2002) Mediators of innate immune recognition of bacteria concentrate in lipid rafts and facilitate lipopolysaccharide-induced cell activation. J Cell Sci 115: 2603-11.
20. Olsson S., Sundler R. (2006) The role of lipid rafts in LPS-induced signaling in a macrophage cell line. Mol Immunol 43: 607-12.
21. Norman A.W., Spielvogel A.M.,Wong R.G. (1976) Polyene antibiotic - sterol interaction. Adv Lipid Res 14: 127-70.